Lexeo Therapeutics (LXEO) Times Interest Earned (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Times Interest Earned of -$8.09 for Q1 2026, up 87.24% on a YoY basis from -$4.32 in Q1 2025, and up 81.03% sequentially from -$42.65 in Q4 2025.
Lexeo Therapeutics (LXEO) Times Interest Earned (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of Times Interest Earned data on file, last reported at -$8.09 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 87.24% year-over-year to -$8.09; the trailing twelve-month figure through Mar 2026 stood at -$35.43 (up 50.58% YoY), and the FY2025 full-year result was -$0.92, up 94.54% from the prior year.
- Times Interest Earned rose to -$8.09 in Q1 2026, from -$42.65 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$1.28 in Q1 2024 to a low of -$379.92 in Q4 2022.
- A 5-year average of -$65.93 and a median of -$27.56 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 96.52% in 2023 and slumped 4867.23% in 2025, its largest moves.
- Tracing LXEO's Times Interest Earned over 5 years: stood at -$379.92 in 2022, then gained by 21.17% to -$299.48 in 2023, then soared by 82.81% to -$51.47 in 2024, then increased by 17.14% to -$42.65 in 2025, then jumped by 81.03% to -$8.09 in 2026.
- Business Quant data shows LXEO's Times Interest Earned at -$8.09 in Q1 2026, -$42.65 in Q4 2025, and -$2.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - | -8.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.09 |
| Dec 31, 2025 | -42.65 |
| Sep 30, 2025 | -2.49 |
| Jun 30, 2025 | -3.32 |
| Mar 31, 2025 | -63.42 |
| Dec 31, 2024 | -51.47 |
| Sep 30, 2024 | -5.71 |
| Jun 30, 2024 | -1.34 |
| Mar 31, 2024 | -1.28 |
| Dec 31, 2023 | -299.48 |
| Sep 30, 2023 | -2.25 |
| Jun 30, 2023 | -27.56 |
| Mar 31, 2023 | -35.20 |
| Dec 31, 2022 | -379.93 |
| Sep 30, 2022 | -64.75 |